Pimecrelimus: A novel treatment for cetuximab-induced papulopustular eruption

Archives of Dermatology

Volumn 144, Issue 9, 2008, Pages 1236-1238

  Eiling, Elisabeth ^b   Brandt, Michael ^b   Schwarz, Thomas ^b   Hauschild, Axel ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; CETUXIMAB; CLINDAMYCIN; EMOLLIENT AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; PIMECROLIMUS; ANTINEOPLASTIC AGENT; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; MONOCLONAL ANTIBODY; TACROLIMUS;

ADD ON THERAPY; ADULT; ASCENDING COLON; CARCINOMATOSIS; CARCINOMATOUS LYMPHANGITIS; CASE REPORT; COLON CANCER; DRUG ERUPTION; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PAPULOPUSTULAR ERUPTION; PERITONEUM METASTASIS; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT RESPONSE; ULCERATIVE COLITIS; XEROSIS; CHEMICALLY INDUCED DISORDER; COLON RESECTION; COLON TUMOR; FEMALE; PATHOLOGY; SKIN DISEASE;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLECTOMY; COLONIC NEOPLASMS; DERMATOLOGIC AGENTS; FEMALE; HUMANS; SKIN DISEASES; TACROLIMUS;

EID: 51949107946     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.9.1236     Document Type: Letter

References (5)

1. Baselga J. Why the epidermal growth factor receptor? the rationale for cancer therapy. Oncologist. 2002;(7)(suppl 4):2-8.
2. Peréz-Soler R, Saltz L. Cutaneous adverse effects with HERl/EGFR-targeted agents: is there a silver lining. J Clin Oncol. 2005;23(22):5235-5246.
3. Lacouture ME, Lai SE. The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome. Br J Dermatol. 2006;155(4): 852-853.
4. Albanell J, Rojo F, Averbuch S, et al. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol. 2002;20(1):110-124.
5. Hu JC, Sadeghi P, Pinter-Brown LC, Pinter-Brown LC, Yashar S, Chiu MW. Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management. J Am Acad Dermatol. 2007; 56(2):317-326.